GO:0061146 Peyer's patch morphogenesis: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061146 describes the biological process by which Peyer's patches, organized lymphoid nodules in the gut, are generated and structured.
• Peyer's patch morphogenesis depends on a programmed inflammatory cascade driven by lymphoid tissue inducer cells and cytokines such as LTα, TNF, and IL-7.
• Key transcription factors including RORγt, ID2, and BOB.1/OBF.1 are required for proper patch formation, as shown by deficient mouse models.
• Single-cell studies of human intestinal development have revealed conserved and species-specific features of immune tissue organization.
• Macrophages and mononuclear phagocytes populate Peyer's patches and contribute to their homeostasis and immune function.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate genes in Peyer's patch morphogenesis.
Description
Peyer's patches are specialized lymphoid follicles located in the small intestine that serve as inductive sites for mucosal immune responses. The process by which these structures are generated and organized is annotated as Peyer's patch morphogenesis (GO:0061146). This developmental program integrates signals from lymphoid tissue inducer cells, stromal cells, and hematopoietic cells to form distinct B-cell and T-cell zones within the gut epithelium. Understanding Peyer's patch morphogenesis is important because these structures are essential for intestinal immune surveillance and for maintaining homeostasis with the microbiota. Disruption of this process can lead to impaired mucosal immunity and increased susceptibility to enteric pathogens. Recent single-cell transcriptomic analyses of human intestinal development have provided a high-resolution view of the cellular diversity and signaling events that underlie lymphoid tissue formation. This article synthesizes the current knowledge of the molecular and cellular mechanisms of Peyer's patch morphogenesis, the genes involved, and the experimental approaches used to study it.
Peyer's patch morphogenesis At A Glance
| GO ID | GO:0061146 |
|---|---|
| GO term | Peyer's patch morphogenesis |
| Ontology | biological_process |
| Synonym | None |
| Major function | Generation and organization of Peyer's patches, including formation of B- and T-cell zones for lymphocyte activation |
| Key cell types | Lymphoid tissue inducer cells, stromal cells, B cells, T cells, macrophages |
| Key cytokines | LTα, TNF, IL-7, and other inflammatory mediators |
| Associated transcription factors | RORγt, ID2, BOB.1/OBF.1 |
| Developmental timing | Initiated during fetal development and maintained postnatally |
What Is GO:0061146?
Peyer's patch morphogenesis (GO:0061146) is the biological process in which a Peyer's patch is generated and organized. Peyer's patches are typically found as nodules associated with the gut epithelium and contain distinct internal structures, including B-cell and T-cell zones that are required for the activation of lymphocytes. This process encompasses the initial clustering of lymphoid tissue inducer cells, the recruitment of hematopoietic cells, the formation of follicular structures, and the establishment of functional zones within the patch.
Why Is Peyer's patch morphogenesis Important in Cell Biology?
Peyer's patch morphogenesis is critical for establishing mucosal immunity in the gut. These organized lymphoid structures are the primary sites where immune cells encounter antigens from the intestinal lumen, leading to the activation of B and T lymphocytes and the production of secretory IgA. Defects in Peyer's patch development result in impaired immune responses to oral pathogens and altered commensal microbiota composition. Therefore, understanding the molecular mechanisms of Peyer's patch morphogenesis has direct implications for vaccine development, inflammatory bowel disease, and gastrointestinal infections.
• Provides the structural basis for intestinal immune surveillance and antigen sampling.
• Essential for the generation of secretory IgA responses against gut pathogens.
• Defects in morphogenesis lead to impaired mucosal immunity and increased susceptibility to enteric infections.
• Involved in the pathogenesis of inflammatory bowel diseases such as Crohn's disease.
• Serves as a model for studying lymphoid tissue organogenesis in general.
• Cytokine-driven programmed inflammation is a key mechanism that can be targeted therapeutically.
• Single-cell studies reveal human-specific features of intestinal immune development.
• Macrophage populations within Peyer's patches contribute to tissue homeostasis and immune regulation.
• Transcription factor networks controlling patch formation are conserved across species.
• CRISPR screening can identify novel regulators of Peyer's patch morphogenesis.
What Happens During Peyer's patch morphogenesis?
Initiation by lymphoid tissue inducer cells
In simple terms: Specialized immune cells called lymphoid tissue inducer cells start the process by clustering in the gut.
Peyer's patch morphogenesis begins with the accumulation of lymphoid tissue inducer (LTi) cells in the developing intestine. These cells interact with stromal cells and initiate a signaling cascade that recruits additional hematopoietic cells. The interaction between LTi cells and stromal cells is dependent on lymphotoxin alpha (LTα) and TNF family cytokines.
Cytokine-mediated programmed inflammation
In simple terms: A controlled inflammatory response driven by cytokines helps organize the patch.
The formation of Peyer's patches is characterized by a programmed inflammatory process. Cytokines such as LTα, TNF, and IL-7 create a local inflammatory environment that promotes the recruitment and organization of immune cells. This programmed inflammation is tightly regulated to avoid excessive tissue damage.
Formation of B-cell and T-cell zones
In simple terms: The patch organizes into distinct areas for B cells and T cells.
As the patch develops, it becomes compartmentalized into B-cell follicles and T-cell zones. This organization is essential for the activation of lymphocytes and the generation of immune responses. The spatial segregation of B and T cells is guided by chemokines and stromal cell networks.
Role of transcription factors
In simple terms: Master regulators inside cells control the genes needed for patch formation.
Transcription factors such as RORγt, ID2, and BOB.1/OBF.1 are critical for Peyer's patch development. Mice deficient in BOB.1/OBF.1 exhibit impaired Peyer's patch development, demonstrating the importance of this transcriptional regulator. RORγt is required for the differentiation and function of LTi cells.
Contribution of macrophages and mononuclear phagocytes
In simple terms: Macrophages help maintain the patch and support immune functions.
Peyer's patches contain a diverse population of mononuclear phagocytes, including macrophages, that contribute to tissue homeostasis and immune regulation. Self-maintaining gut macrophages are essential for intestinal homeostasis and are present within Peyer's patches.
Key Genes Involved in GO:0061146 Peyer's patch morphogenesis
The following genes and proteins have been experimentally implicated in Peyer's patch morphogenesis and related lymphoid tissue development.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LTα | Cytokine that signals through LTβR to initiate lymphoid tissue formation | Knockout mice lack Peyer's patches |
| TNF | Proinflammatory cytokine involved in programmed inflammation | Blockade impairs patch development |
| IL7 | Cytokine supporting LTi cell survival and function | Deficiency leads to impaired patch formation |
| RORC (RORγt) | Transcription factor required for LTi cell differentiation | Knockout mice lack LTi cells and Peyer's patches |
| ID2 | Transcription factor regulating lymphoid tissue inducer cell fate | Deficiency results in absence of Peyer's patches |
| POU2AF1 (BOB.1/OBF.1) | Transcriptional coactivator important for B-cell development | Deficient mice show impaired Peyer's patch development |
| LTBR | Receptor for LTα1β2 on stromal cells | Essential for stromal cell activation |
| CCL19 | Chemokine guiding T-cell zone formation | Involved in lymphocyte recruitment |
| CCL21 | Chemokine guiding T-cell zone formation | Involved in lymphocyte recruitment |
| CXCL13 | Chemokine guiding B-cell follicle formation | Critical for B-cell zone organization |
| VCAM1 | Adhesion molecule on stromal cells | Supports LTi cell clustering |
| ICAM1 | Adhesion molecule on stromal cells | Supports LTi cell clustering |
| TNFSF11 (RANKL) | Cytokine involved in lymphoid tissue organization | May influence patch development |
| IL22 | Cytokine produced by ILC3 cells | Contributes to intestinal homeostasis |
| LYVE1 | Marker for lymphatic vessels | Used to study patch vasculature |
| CD68 | Macrophage marker | Identifies mononuclear phagocytes in patches |
| ITGAX (CD11c) | Dendritic cell marker | Identifies dendritic cells in patches |
How Is Peyer's patch morphogenesis Regulated?
Peyer's patch morphogenesis is regulated by a complex network of cytokines and transcription factors. The lymphotoxin pathway, involving LTα and LTβR, is a central regulator that activates stromal cells to produce chemokines and adhesion molecules. TNF signaling amplifies the inflammatory cascade. Transcription factors such as RORγt and ID2 control the differentiation and function of lymphoid tissue inducer cells. Additionally, BOB.1/OBF.1 is required for proper B-cell development within the patch. The process is also influenced by the intestinal microbiota, which can modulate immune cell recruitment and activation.
Peyer's patch morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POU2AF1 (BOB.1/OBF.1) | Impaired Peyer's patch development and immunodeficiency | Knockout mouse |
| LTα | Defective lymphoid organogenesis | Knockout mouse |
| RORC | Lack of LTi cells and Peyer's patches | Knockout mouse |
| ID2 | Absence of Peyer's patches | Knockout mouse |
| TNF | Inflammatory bowel disease | Knockout or transgenic mouse |
Inflammatory Bowel Disease
Alterations in Peyer's patch morphogenesis and function have been associated with inflammatory bowel diseases, including Crohn's disease. Dysregulated cytokine signaling in the gut can lead to abnormal lymphoid tissue formation and chronic inflammation. Understanding the morphogenetic program may reveal therapeutic targets for modulating mucosal immunity.
Immunodeficiency
Defects in genes required for Peyer's patch development, such as BOB.1/OBF.1, can result in impaired mucosal immunity and increased susceptibility to infections. Patients with mutations in these pathways may present with recurrent gastrointestinal infections.
Gut Homeostasis and Microbiota
Peyer's patches are essential for maintaining homeostasis with the intestinal microbiota. Disruption of patch development can lead to dysbiosis and altered immune responses. Macrophages within Peyer's patches play a key role in this balance.
From Peyer's patch morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate Peyer's patch initiation? | Knockout mouse (constitutive or conditional) |
| Does a point mutation in gene Y affect patch organization? | Point-mutation knock-in mouse |
| Can overexpression of gene Z rescue patch defects? | Transgenic overexpression mouse |
| Where is protein X expressed during patch development? | Tagged knock-in (e.g., GFP) mouse |
| What is the transcriptional profile of LTi cells? | Single-cell RNA-seq of sorted cells |
| How do macrophages contribute to patch homeostasis? | Macrophage-specific knockout mouse |
How to Study the Peyer's patch morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptomes of individual cells | Identifying cell types in developing intestine |
| Immunofluorescence | Protein localization and tissue structure | Visualizing B and T cell zones |
| Flow cytometry | Cell surface marker expression | Quantifying immune cell populations |
| qRT-PCR | Gene expression levels | Validating knockout effects |
| Western blot | Protein expression and modification | Assessing signaling pathways |
| In situ hybridization | RNA localization in tissue | Mapping cytokine expression |
| CRISPR screening | Gene function at scale | Identifying novel regulators of morphogenesis |
Single-cell transcriptomics
Single-cell RNA sequencing has been used to map the cellular diversity of the developing human intestine, including immune cell populations that contribute to Peyer's patch formation. This method allows researchers to identify novel cell types and signaling pathways involved in morphogenesis.
Immunofluorescence and imaging
Immunofluorescence staining of tissue sections can visualize the spatial organization of B-cell and T-cell zones within Peyer's patches. Confocal microscopy provides high-resolution images of patch structure and cellular interactions.
Flow cytometry
Flow cytometry is used to quantify and characterize immune cell populations, such as LTi cells, macrophages, and dendritic cells, within Peyer's patches. This technique enables the analysis of cell surface markers and intracellular cytokines.
Gene expression analysis
Quantitative PCR and RNA-seq can measure the expression of genes involved in Peyer's patch morphogenesis, such as cytokines and transcription factors. These methods are useful for validating findings from knockout or overexpression models.
How CRISPR Can Be Used to Study GO:0061146 Peyer's patch morphogenesis
Knockout
CRISPR knockout models are used to delete candidate genes in mice or cell lines to test their requirement for Peyer's patch morphogenesis. For example, knockout of POU2AF1 (BOB.1/OBF.1) leads to impaired patch development. Knockout of LTα or RORC results in the absence of Peyer's patches.
Point Mutation
Point mutations can be introduced to model specific amino acid changes that may affect protein function without completely abolishing expression. This approach is useful for studying the impact of human variants on Peyer's patch development.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags allows visualization and tracking of specific cell populations or proteins during Peyer's patch morphogenesis. This can reveal dynamic expression patterns.
Overexpression
Overexpression of candidate genes, such as cytokines or transcription factors, can be achieved via transgenic knock-in or viral delivery. This helps determine whether increased gene dosage is sufficient to drive or enhance patch formation.
How EDITGENE Supports Peyer's patch morphogenesis Research
Researchers studying Peyer's patch morphogenesis-related genes often need to determine whether a candidate gene is causally involved in the process. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout and point-mutation models to knock-in reporters and overexpression systems.
Contact EDITGENE today to design your custom CRISPR model for Peyer's patch morphogenesis research.
Frequently Asked Questions About Peyer's patch morphogenesis
What is Peyer's patch morphogenesis?
Peyer's patch morphogenesis (GO:0061146) is the biological process by which Peyer's patches, organized lymphoid nodules in the gut, are generated and structured, including the formation of B-cell and T-cell zones.
What genes are involved in Peyer's patch morphogenesis?
Key genes include LTα, TNF, IL7, RORC, ID2, and POU2AF1 (BOB.1/OBF.1), as demonstrated by knockout mouse studies.
What is the role of lymphoid tissue inducer cells in Peyer's patch formation?
Lymphoid tissue inducer (LTi) cells initiate Peyer's patch formation by clustering in the gut and interacting with stromal cells through cytokines like LTα and TNF.
How is Peyer's patch morphogenesis regulated?
It is regulated by a cytokine network involving LTα, TNF, and IL-7, and by transcription factors such as RORγt and ID2.
What diseases are associated with defective Peyer's patch development?
Defects can lead to immunodeficiency, inflammatory bowel disease, and increased susceptibility to enteric infections.
What model organisms are used to study Peyer's patch morphogenesis?
Mice are the primary model, with knockout, knock-in, and transgenic strains available for key genes.
Can CRISPR be used to study Peyer's patch morphogenesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in mice and cell lines.
What is the role of macrophages in Peyer's patches?
Macrophages contribute to tissue homeostasis and immune regulation within Peyer's patches.
How does single-cell RNA-seq help study Peyer's patch development?
It reveals the cellular diversity and transcriptional programs of immune and stromal cells during intestinal development.
What are the key signaling pathways in Peyer's patch organogenesis?
The lymphotoxin and TNF signaling pathways are central, along with chemokine gradients that organize B and T cell zones.
Conclusion
Peyer's patch morphogenesis (GO:0061146) is a complex developmental process driven by programmed inflammation and cytokine signaling. Key genes such as LTα, RORC, ID2, and POU2AF1 have been identified through mouse knockout studies, and single-cell technologies continue to reveal new cellular players. Understanding this process is essential for mucosal immunology and for developing therapies for inflammatory bowel diseases and immunodeficiency. EDITGENE's CRISPR services provide powerful tools to dissect the genetic basis of Peyer's patch morphogenesis and to accelerate translational research.
References
- 1. Fawkner-Corbett D et al.. 2021. Spatiotemporal analysis of human intestinal development at single-cell resolution.. Cell 184(3):810-826.e23 PMID: 33406409
- 2. De Schepper S et al.. 2018. Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis.. Cell 175(2):400-415.e13 PMID: 30173915
- 3. Betzler AC et al.. 2021. Impaired Peyer's patch development in BOB.1/OBF.1-deficient mice.. Eur J Immunol 51(7):1860-1863 PMID: 33733501
- 4. Gogoleva VS et al.. 2022. LTα, TNF, and ILC3 in Peyer's Patch Organogenesis.. Cells 11(12) PMID: 35741098
- 5. Mayrhofer G. 1997. Peyer's patch organogenesis--cytokines rule, OK?. Gut 41(5):707-9 PMID: 9414984
- 6. Bonnardel J et al.. 2015. Specificity and diversity of the mouse Peyer's patch mononuclear phagocyte system.. Oncotarget 6(19):16788-9 PMID: 26220207
- 7. Finke D et al.. 2001. Formation of Peyer's patches.. Curr Opin Genet Dev 11(5):561-7 PMID: 11532399
- 8. Nishikawa S et al.. 1998. Peyer's patch organogenesis as a programmed inflammation: a hypothetical model.. Cytokine Growth Factor Rev 9(3-4):213-20 PMID: 9918121
